Tag «LGX 818»

ENCORAFENIB, エンコラフェニブ

It’s only fair to share… ENCORAFENIB, エンコラフェニブ UNII:8L7891MRB6 Formula:C22H27ClFN7O4S, Average: 540.01 1269440-17-6 BRAFTOVI NVP-LGX818 NVP-LGX-818-NXA NVP-LGX818-NXA ENCORAFENIB [USAN] ENCORAFENIB [WHO-DD] ENCORAFENIB ENCORAFENIB [INN] METHYL N-((2S)-1-((4-(3-(5-CHLORO-2-FLUORO-3-(METHANESULFONAMIDO)PHENYL)(-1-(PROPAN-2-YL)-1H-PYRAZOL-4-YL(PYRIMIDIN-2-YL)AMINO)PROPAN-2-YL)CARBAMATE CARBAMIC ACID, N-((1S)-2-((4-(3-(5-CHLORO-2-FLUORO-3-((METHYLSULFONYL)AMINO)PHENYL)-1-(1-METHYLETHYL)-1H-PYRAZOL-4-YL)-2-PYRIMIDINYL)AMINO)-1-METHYLETHYL)-, METHYL ESTER LGX818 LGX-818 Encorafenib, also known as BRAFTOVI, is a kinase inhibitor. Encorafenib inhibits BRAF gene, which encodes for B-raf protein, which is a proto-oncogene involved in various genetic …